31 MayOrgan specific provides Stem Cells in Syringes for in vivo applications known Celprogen Inc bestil her.

Organ specific provides Stem Cells in Syringes for in vivo applications – known Celprogen Inc., a world leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies in regenerative medicine, announced that it successfully delivery of adult and embryonic validated stem cells at room temperature within United States of research facilities for in vivo applications. These Stems including progenitor cells were derived from the following species mouse, rat and human bestil her .

Celprogen the stem and progenitor cells in the syringes are for basic research and drug development. The stem cells in the syringe shipment are validated as follows: hepatocytes, neural, pancreatic, cardiomyocytes, colon, lung and keratinocytes. These stem cells are in their syringes in a position to maintain their stem – ness and are able to remember injected on their organ-specific sites once delivered within 3 to 5 days of the date. Successfully stem Celprogen world at room temperature in cell culture bottles shipped to Asia, Europe and the UK.

Yet movement limitations in British Columbia Lifted.